Daewoong pharmaceutical

069620.KO

120.57 USD

-0.77

-0.63%

Overview

Last close

120.57 usd

Market cap

1.39B usd

52 week high

131.00 usd

52 week low

76.68 usd

Target price

143.8 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.333

Price/Book Value

2.3474

Enterprise Value

1.79B usd

EV/Revenue

1.7188

EV/EBITDA

15.1595

Key financials

Revenue TTM

1.04B usd

Gross Profit TTM

540.66M usd

EBITDA TTM

161.91M usd

Earnings per Share

N/A usd

Dividend

0.41 usd

Total assets

1.61B usd

Net debt

418.75M usd

About

Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.